New Treatment for Seizures
What is perampanel?
Perampanel (the generic name), also known as Fycompa (the brand name), is a prescription medicine used alone or with other medicines to treat focal seizures (previously called partial seizures) with or without secondarily generalized seizures in people with epilepsy. It is not yet approved for LGS but is often used by patients with LGS who have specific seizure types.
Watch Now: Overview of Fycompa for Seizures
Presented by: Michael Chez, MD, Pediatric Epileptologist, Sutter Health, California
*Dr. Michael Chez is a Pediatric Epilepsy Expert and regularly treats LGS patients. This video was recorded in early 2022 at the request of the LGS Foundation to provide information to our family members about this medication. The Foundation does not endorse this or any product and is here only to provide information relevant to patient families.
Additional Clinical Trial Information:
LEARN MORE: www.FYCOMPA.com.
READ MORE: Perampanel Effective, Well-Tolerated in Lennox-Gastaut Syndrome
The information here is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. The content provided is for informational purposes only. LGS Foundation is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health related diagnosis or treatment options.
Updated 8/27/22
